Aligos Therapeutics (ALGS)
(Delayed Data from NSDQ)
$7.40 USD
+0.19 (2.64%)
Updated Oct 18, 2024 10:09 AM ET
4-Sell of 5 4
F Value C Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-2.15 | 0.00% |
Earnings Summary
For their last quarter, Aligos Therapeutics (ALGS) reported earnings of $0.75 per share, beating the Zacks Consensus Estimate of $-4.00 per share. This reflects a positive earnings surprise of 118.75%. Look out for ALGS's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$2.15 per share, reflecting a year-over-year increase of 79.02%.
Earnings History
Price & Consensus
Zacks News for ALGS
How Much Upside is Left in Aligos Therapeutics (ALGS)? Wall Street Analysts Think 648.14%
ALGS: What are Zacks experts saying now?
Zacks Private Portfolio Services